Objective:

To identify clinical and laboratory predictors of CD3+ T-cell depletion and develop a machine learning model for predicting attainment of predefined therapeutic CD3+ T-cell thresholds following ATG induction therapy in kidney transplant recipients.

Approach:

Key Findings:

• In the analysis of 397 transplant patients, 57.2% achieved day-1 CD3+ T-cell < 50 cell/μl threshold.
• 57.5% reached day-2 CD3+ T-cell < 30 cell/μl threshold.
• Machine learning model ROC-AUC values were 0.75 and 0.80 for Day 1, and 0.70 and 0.66 for Day 2 predictions.
• The machine learning model outperformed logistic regression in predicting CD3+ T-cell count thresholds.

Interpretation:

The study suggests that clinical response to ATG treatment can be predicted using accessible laboratory tests and patient characteristics without requiring CD3+ T-cell quantification.

Limitations:

• Retrospective study design may introduce bias.
• Generalizability may be limited to the specific patient population studied.

Conclusion:

The findings provide a framework for developing more accurate machine learning models for predicting ATG treatment effects in kidney transplant patients.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.